Response to: Neutralizing Antibodies to Botulinum Toxin Type A Are Rare Following Aesthetic Indications
Aesthet Surg J
.
2021 Oct 15;41(11):NP1802-NP1803.
doi: 10.1093/asj/sjab319.
Authors
Eqram Rahman
1
,
Ash Mosahebi
1
Affiliation
1
Department of Plastic and Reconstructive Surgery at Royal Free Hospital, University College London, London, UK.
PMID:
34410297
DOI:
10.1093/asj/sjab319
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Neutralizing
Botulinum Toxins, Type A* / adverse effects
Esthetics
Humans
Neuromuscular Agents* / adverse effects
Substances
Antibodies, Neutralizing
Neuromuscular Agents
Botulinum Toxins, Type A